Channels - TNFAIP3 Reprograms T Cell Exhaustion and Restores Anti-Leukemia Immunity in Acute Myeloid Leukemia :: FRELIP Discovery

Similar Items: TNFAIP3 Reprograms T Cell Exhaustion and Restores Anti-Leukemia Immunity in Acute Myeloid Leukemia

Quick Look
Mutant NPM1 in Acute Myeloid Leukemia Initiation and Maintenance
Quick Look
Aging Is a Key Driver for Adult Acute Myeloid Leukemia
Quick Look
Prognostic Impact of European LeukemiaNet Genetic Risk Stratification System in Adult Patients With Acute Myeloid Leukemia
Quick Look
Clinical implications of variant allele frequencies of genes in patients with acute myeloid leukemia
Quick Look
Construction and Validation of an N7-Methylguanosine–Related Prognostic Model for Acute Myeloid Leukemia
Quick Look
Metabolic Subtypes Predict Treatment Response in Acute Myeloid Leukemia: A Pilot Study
Quick Look
Gain and Loss of Mutations in Patients with Acute Myeloid Leukemia: A Noninterventional Cohort Study (CLEVO)
Quick Look
Exploring the Bone Marrow Microenvironment as a Therapeutic Barrier and Targetable Source of Crosstalk in Acute Myeloid Leukemia
Quick Look
Study on the Role of Neutrophil Extracellular Traps-Based Risk Model and Discriminative Gene LTF in the Prognosis of Acute Myeloid Leukemia and the Regulation of Immune Microenvironment
Quick Look
Health Disparities in Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2
Quick Look
Challenges faced in the treatment of acute lymphoblastic leukemia in adolescents and young adults
Quick Look
Acute lymphoblastic leukemia in adolescents and young adults – from genomics to the clinics
Quick Look
Thyroid profile in acute lymphoblastic leukemia: prognostic role of thyrotropin-releasing hormone
Quick Look
Crosstalk Between FOXN3 and E2F5 Reveals a Novel Tumor Suppressive Pathway in Acute Myeloid Leukemia via MAPK Signaling: Implications for Potential Future Targeted Therapy
Quick Look
Safety and Efficacy of Flumatinib in Patients with Chronic Phase Chronic Myeloid Leukemia: A Real-Life Cohort Observational Study
Quick Look
Early assessment of endocan level as a predictor of remission status in acute leukemia patients
Quick Look
Community Experience With Pediatric‐Inspired Regimens for Acute Lymphoblastic Leukemia in Adolescent and Young Adults
Quick Look
Long-Term Results of Busulfan Plus High-Dose Idarubicin as a Conditioning Regimen to Autologous Stem Cell Transplantation Following Cytarabine Consolidation in Young Patients with Favorable or Intermediate-Risk Acute Myeloid Leukemia
Quick Look
Venetoclax Plus Blinatumoma as First Line Therapy for Newly Diagnosed Ph-Negative B-Cell Acute Lymphoblastic Leukemia
Quick Look
Molecular Response to Treatment of Chronic Myeloid Leukemia at University Teaching Hospital of Kigali, Rwanda: One-Arm Open Label Prospective Observational Study
Quick Look
Descriptive Epidemiology and Prognosis of Pediatric Acute Leukemia in the Afro‐Descendant Population of the French West Indies and French Guiana
Quick Look
A Comprehensive Review of the Role of Zanubrutinib for Patients with Chronic Lymphocytic Leukemia
Quick Look
Association of Variants in Candidate Pharmacogenes with Response to Mercaptopurine and Methotrexate in Pediatric Acute Lymphoblastic Leukemia: A Single-Center Experience from Croatia
Quick Look
Association Between Petroleum Compounds Exposure and Risk of Childhood Leukemia: A Systematic Review